StockNews.com assumed coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Free Report) in a report issued on Saturday. The firm issued a hold rating on the biopharmaceutical company’s stock.
Sorrento Therapeutics Price Performance
Shares of SRNE opened at $0.00 on Friday. Sorrento Therapeutics has a 1 year low of $0.00 and a 1 year high of $0.08.
About Sorrento Therapeutics
Featured Articles
- Five stocks we like better than Sorrento Therapeutics
- What Are Dividend Challengers?
- Can TikTok Stock Picks Really Make You Rich?
- Best Stocks Under $5.00
- The “Quality” Rotation: Back to Basics Investing
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Occidental Petroleum: 4 Reasons to Love These Prices
Receive News & Ratings for Sorrento Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sorrento Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.